Clinical Trial Update: Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of intratympanic injections of mesenchymal stem cell–derived small extracellular vesicles for seve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Drugs mentioned

• Mesenchymal stem cell–derived extracellular vesicles for intratympanic injection (mesenchymal stem cell–derived extracellular vesicles)

Snippet

Sponsor: The Affiliated Hospital of Qingdao University | Conditions: Sudden Hearing Loss, Extracellular Vesicles | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING